75 Participants Needed

Brain Training for Mild Cognitive Impairment

JG
Overseen ByJoseph Gullett, Ph.D.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether brain training can improve memory in individuals with mild cognitive issues related to memory. Researchers will use brain scans to predict who might benefit most from the training. Participants will either engage in a specific brain training program (called TRAIN) or participate in other mentally stimulating computer activities. The trial seeks individuals who have noticed memory changes but can still manage daily tasks independently. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research on cognitive health.

Will I have to stop taking my current medications?

The trial does not specify if you must stop taking your current medications, but you cannot use antipsychotics, sedatives, or medications with significant anticholinergic properties. Also, you should not use photo-sensitive medications like steroids or retin-A within 15 days of the study.

What prior data suggests that this cognitive training intervention is safe for individuals with mild cognitive impairment?

Research has shown that computerized brain training is generally safe and well-tolerated. Studies have tested this type of training, such as the one used in the TRAIN program, on people with mild memory and thinking problems without major safety concerns. Participants typically perform the exercises on a computer, which includes activities to enhance memory and thinking skills.

In these studies, few side effects were reported. Most participants found the training manageable, experiencing only minor issues like eye strain or tiredness, similar to what one might feel after extended computer use. No serious side effects were reported. This suggests that the brain training used in this trial is likely safe for people with mild cognitive issues.12345

Why are researchers excited about this trial?

Researchers are excited about the cognitive training being tested because it offers a non-drug approach to managing mild cognitive impairment. Unlike the standard medications that primarily target symptoms, this method focuses on enhancing brain function through interactive exercises. Delivered via the Posit Science Brain HQ platform, it provides a personalized experience that adapts to individual progress, potentially leading to significant cognitive improvements over time. This tech-driven approach represents a shift towards leveraging digital tools for brain health, making it an innovative option in the field.

What evidence suggests that this cognitive training intervention is effective for mild cognitive impairment?

Research has shown that computer-based brain exercises can improve memory in people with mild cognitive impairment (MCI). In this trial, participants in the intervention group will use a cognitive training program called TRAIN, which involves interactive brain exercises. One study found that an interactive tool for brain exercises was promising for patients with Alzheimer's, a condition similar to MCI. Researchers also found that personalized brain training programs can be effective for people with MCI. These programs boost brain function through specific exercises. Early results suggest that these training methods could help manage MCI symptoms.12356

Who Is on the Research Team?

JG

Joseph M Gullett, PhD

Principal Investigator

University of Florida

Are You a Good Fit for This Trial?

This trial is for older adults with mild cognitive impairment who have a close informant to report on their cognition, can handle daily activities despite some difficulties, and score within normal limits on a cognitive screening. They must not be dependent on certain medications or have conditions like dementia, major psychiatric disturbances, uncontrolled medical issues, or past participation in similar studies.

Inclusion Criteria

Global clinical dementia rating scale (CDR) score must be equal to 0.5
Cognitive performance on one or more standardized neuropsychological measures of verbal or non-verbal memory > 1.0 standard deviation or more below the normative mean for age and education
No evidence of dementia based on cognitive screening (Montreal Cognitive Assessment Score within normal limits for age, education, and sex using the NACC Uniform Data Set (UDS) norms.
See 6 more

Exclusion Criteria

Previous participation in a cognitive training study within the last 6 months or current involvement in another study involving cognitive, physical or other intervention at the time of participation.
I do not have any uncontrolled health conditions or a current cancer diagnosis.
I do not have significant vision or hearing loss that would prevent me from participating in study tasks.
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Baseline brain MRI sequences and neuropsychological assessments are conducted

1 month
1 visit (in-person)

Treatment

Participants undergo cognitive training using the Posit Science Brain HQ Suite for 16 weeks

16 weeks
Self-administered 2-3 days/week

Follow-up

Participants are monitored for cognitive improvements and changes in UFOV composite score

12 weeks
Assessments at end of treatment

What Are the Treatments Tested in This Trial?

Interventions

  • TRAIN
Trial Overview The TRAIN study uses brain MRI data from participants to train an AI tool that predicts how well they'll respond to computerized cognitive training designed for those with memory impairments. Participants will either receive this training or educational training (control) over 12 weeks.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group: Cognitive TrainingExperimental Treatment1 Intervention
Group II: Active Control Group: Computerized Cognitive StimulationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Florida

Lead Sponsor

Trials
1,428
Recruited
987,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Published Research Related to This Trial

This study will evaluate the effectiveness of home-based computerized cognitive training (CCT) in improving cognitive abilities in 100 patients with mild cognitive impairment (MCI) over 12 weeks, with follow-up booster sessions for up to 78 weeks.
The trial aims to assess not only cognitive improvements but also changes in brain structure and function, specifically looking at hippocampal volume and the default mode network, using MRI scans, making it a comprehensive approach to understanding the impact of CCT on MCI.
Cognitive training and neuroplasticity in mild cognitive impairment (COG-IT): protocol for a two-site, blinded, randomised, controlled treatment trial.D'Antonio, J., Simon-Pearson, L., Goldberg, T., et al.[2020]
A pilot study involving 32 older adults with Mild Cognitive Impairment (MCI) found that Gist Reasoning training led to significant changes in neural activity, specifically increased theta synchronization and enhanced alpha band desynchronization during cognitive tasks, indicating improved neural processing.
The results suggest that Gist Reasoning training may be more effective than New Learning training in promoting neuroplasticity and cognitive function in individuals with MCI, particularly in tasks requiring higher-order reasoning.
Event-related neural oscillation changes following reasoning training in individuals with Mild Cognitive Impairment.Mudar, RA., Nguyen, LT., Eroh, J., et al.[2022]
In a pilot study involving 20 elderly patients with mild cognitive impairment (MCI), sensorimotor (SMR)/theta neurofeedback training over 10 weeks led to significant improvements in cognitive assessments, including the Montreal Cognitive Assessment and the Wechsler Adult Intelligence Scale.
The training also resulted in increased EEG theta and alpha power, indicating enhanced brain activity, with these improvements sustained at a 1-month follow-up, suggesting that neurofeedback could be a promising non-invasive method for cognitive rehabilitation in the elderly.
SMR/Theta Neurofeedback Training Improves Cognitive Performance and EEG Activity in Elderly With Mild Cognitive Impairment: A Pilot Study.Marlats, F., Bao, G., Chevallier, S., et al.[2020]

Citations

Training Response Artificial Intelligence Network (TRAIN)This study will train a machine learning tool to predict response to a cognitive training intervention using baseline brain MRI sequences ...
Computer-Based Cognitive Training for Mild ...A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease. J Neurol Neurosurg ...
Computerized cognitive training for memory functions in ...A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease. ... training ...
Review Cognitive intervention for persons with mild ...Researchers report that errorless learning is an effective memory rehabilitation tool for persons with MCI (Akhtar et al., 2006). Schreiber and Schneider (2007) ...
Individualised computerised cognitive training (iCCT) for ...Cognitive intervention programmes on patients affected by mild cognitive impairment: a promising intervention tool for MCI? J Nutr Health ...
Dual-Task Training for People With Mild Cognitive ...This instrument consists of a 19-item self-rated questionnaire to assess sleep quality during the last month, which includes seven domains, i.e., subjective ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security